Rhabdomyosarcoma, Early Onset

R. Beverly Raney; H. M. Maurer

doi:10.1016/B978-0-12-801238-3.04446-9

Rhabdomyosarcoma, Early Onset

R. Beverly Raney, H. M. Maurer

Pediatrics Hematology/Oncology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Rhabdomyosarcoma is a malignant tumor which occurs mostly in children and adolescents less than 21 years of age. It arises from primitive mesenchyme and presents as a mass in virtually any location in the body. This article provides an up-to-date summary of the important advances made in elucidating the natural history and biology of the disease, along with results of primarily North American clinical research trials of treatment with surgery, radiation therapy, and chemotherapy. [Word Count, 74].

Original language	English (US)
Title of host publication	Reference Module in Biomedical Research
Publisher	Elsevier Inc.
ISBN (Print)	9780128012383
DOIs	https://doi.org/10.1016/B978-0-12-801238-3.04446-9
State	Published - Dec 15 2014

Keywords

Pathobiology and clinical
Recent results of therapy
Rhabdomyosarcoma in children and adolescents
Trials

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/B978-0-12-801238-3.04446-9

Fingerprint Dive into the research topics of 'Rhabdomyosarcoma, Early Onset'. Together they form a unique fingerprint.

Cite this

Beverly Raney, R., & Maurer, H. M. (2014). Rhabdomyosarcoma, Early Onset. In Reference Module in Biomedical Research Elsevier Inc.. https://doi.org/10.1016/B978-0-12-801238-3.04446-9

@inbook{a277311d8d014baa835814da64a2c67c,

title = "Rhabdomyosarcoma, Early Onset",

abstract = "Rhabdomyosarcoma is a malignant tumor which occurs mostly in children and adolescents less than 21 years of age. It arises from primitive mesenchyme and presents as a mass in virtually any location in the body. This article provides an up-to-date summary of the important advances made in elucidating the natural history and biology of the disease, along with results of primarily North American clinical research trials of treatment with surgery, radiation therapy, and chemotherapy. [Word Count, 74].",

keywords = "Pathobiology and clinical, Recent results of therapy, Rhabdomyosarcoma in children and adolescents, Trials",

author = "{Beverly Raney}, R. and Maurer, {H. M.}",

year = "2014",

month = dec,

day = "15",

doi = "10.1016/B978-0-12-801238-3.04446-9",

language = "English (US)",

isbn = "9780128012383",

booktitle = "Reference Module in Biomedical Research",

publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Rhabdomyosarcoma, Early Onset

AU - Beverly Raney, R.

AU - Maurer, H. M.

PY - 2014/12/15

Y1 - 2014/12/15

N2 - Rhabdomyosarcoma is a malignant tumor which occurs mostly in children and adolescents less than 21 years of age. It arises from primitive mesenchyme and presents as a mass in virtually any location in the body. This article provides an up-to-date summary of the important advances made in elucidating the natural history and biology of the disease, along with results of primarily North American clinical research trials of treatment with surgery, radiation therapy, and chemotherapy. [Word Count, 74].

AB - Rhabdomyosarcoma is a malignant tumor which occurs mostly in children and adolescents less than 21 years of age. It arises from primitive mesenchyme and presents as a mass in virtually any location in the body. This article provides an up-to-date summary of the important advances made in elucidating the natural history and biology of the disease, along with results of primarily North American clinical research trials of treatment with surgery, radiation therapy, and chemotherapy. [Word Count, 74].

KW - Pathobiology and clinical

KW - Recent results of therapy

KW - Rhabdomyosarcoma in children and adolescents

KW - Trials

UR - http://www.scopus.com/inward/record.url?scp=84945362338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945362338&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801238-3.04446-9

DO - 10.1016/B978-0-12-801238-3.04446-9

M3 - Chapter

SN - 9780128012383

BT - Reference Module in Biomedical Research

PB - Elsevier Inc.

ER -